blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3084439

EP3084439 - ANALYSIS OF ANTIBODIES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.07.2019
Database last updated on 15.01.2025
FormerThe patent has been granted
Status updated on  17.08.2018
FormerGrant of patent is intended
Status updated on  16.04.2018
FormerExamination is in progress
Status updated on  29.09.2017
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY, HU, MK		published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
Phadia AB
Box 6460
751 37 Uppsala / SE
[2016/43]
Inventor(s)01 / MOVÉRARE, Robert
Phadia
Box 6460
S-751 37 Uppsala / SE
02 / ERIKSSON, Camilla
Phadia
Box 6460
S-751 37 Uppsala / SE
03 / VENEMALM, Lennart
Phadia
Box 6460
S-751 37 Uppsala / SE
 [2016/43]
Representative(s)Brann AB
P.O. Box 3690
Sveavägen 63
103 59 Stockholm / SE
[N/P]
Former [2016/43]Brann AB
P.O. Box 3690
Drottninggatan 27
103 59 Stockholm / SE
Application number, filing date14824416.316.12.2014
[2016/43]
WO2014EP77897
Priority number, dateUS201361919156P20.12.2013         Original published format: US 201361919156 P
US201462019945P02.07.2014         Original published format: US 201462019945 P
[2016/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015091438
Date:25.06.2015
Language:EN
[2015/25]
Type: A1 Application with search report 
No.:EP3084439
Date:26.10.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 25.06.2015 takes the place of the publication of the European patent application.
[2016/43]
Type: B1 Patent specification 
No.:EP3084439
Date:19.09.2018
Language:EN
[2018/38]
Search report(s)International search report - published on:EP25.06.2015
ClassificationIPC:G01N33/543, G01N33/68
[2016/43]
CPC:
G01N33/6854 (EP,US); G01N33/54353 (EP,US); G01N33/94 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/43]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ANALYSE VON ANTIKÖRPERN[2016/43]
English:ANALYSIS OF ANTIBODIES[2016/43]
French:ANALYSE D'ANTICORPS[2016/43]
Entry into regional phase15.06.2016National basic fee paid 
15.06.2016Designation fee(s) paid 
15.06.2016Examination fee paid 
Examination procedure20.10.2015Request for preliminary examination filed
International Preliminary Examining Authority: EP
15.06.2016Examination requested  [2016/43]
28.09.2017Despatch of a communication from the examining division (Time limit: M04)
06.02.2018Reply to a communication from the examining division
17.04.2018Communication of intention to grant the patent
13.08.2018Fee for grant paid
13.08.2018Fee for publishing/printing paid
13.08.2018Receipt of the translation of the claim(s)
Opposition(s)20.06.2019No opposition filed within time limit [2019/35]
Fees paidRenewal fee
13.12.2016Renewal fee patent year 03
12.12.2017Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.12.2014
AL19.09.2018
CY19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
MK19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
TR19.09.2018
IE16.12.2018
LU16.12.2018
MT16.12.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
BE31.12.2018
IS19.01.2019
PT19.01.2019
[2020/31]
Former [2020/17]AL19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
TR19.09.2018
IE16.12.2018
LU16.12.2018
MT16.12.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
BE31.12.2018
IS19.01.2019
PT19.01.2019
Former [2020/08]AL19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
IE16.12.2018
LU16.12.2018
MT16.12.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
BE31.12.2018
IS19.01.2019
PT19.01.2019
Former [2019/50]AL19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
IE16.12.2018
LU16.12.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
BE31.12.2018
IS19.01.2019
PT19.01.2019
Former [2019/48]AL19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SK19.09.2018
SM19.09.2018
IE16.12.2018
LU16.12.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
Former [2019/40]AL19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SK19.09.2018
SM19.09.2018
LU16.12.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
Former [2019/39]AL19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SK19.09.2018
SM19.09.2018
LU16.12.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
Former [2019/26]AL19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SK19.09.2018
SM19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
Former [2019/24]AL19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SK19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
Former [2019/22]AL19.09.2018
CZ19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
Former [2019/21]AL19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
RS19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
Former [2019/12]AL19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
RS19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
Former [2019/11]FI19.09.2018
HR19.09.2018
LT19.09.2018
RS19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
Former [2019/08]FI19.09.2018
LT19.09.2018
NO19.12.2018
Former [2019/07]LT19.09.2018
Cited inInternational search[X]WO2010003602  (ATHERA BIOTECHNOLOGIES AB [SE], et al) [X] 1,9-20 * the whole document * * p. 8-9, bridging paragraph * * claims 6, 10 *;
 [X]US2011183363  (FISCHER SALOUMEH [US], et al) [X] 1-20 * the whole document * * figures 7-17 * * claim 25 * * paragraph [0180] *;
 [X]WO2012010290  (ATHERA BIOTECHNOLOGIES AB [SE], et al) [X] 1,9-20 * the whole document * * page 13, paragraph 3 * * page 23, paragraph 4 *;
 [X]WO2013132000  (HOFFMANN LA ROCHE [CH], et al) [X] 1-20 * the whole document * * page 17, line 23 - page 19, line 15 *;
 [X]  - STUBENRAUCH K ET AL, "Evaluation of a biosensor immunoassay for simultaneous characterization of isotype and binding region of human anti-tocilizumab antibodies with control by surrogate standards", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS INC, NEW YORK, vol. 390, no. 2, doi:10.1016/J.AB.2009.04.021, ISSN 0003-2697, (20090715), pages 189 - 196, (20090418), XP026145499 [X] 1-20 * the whole document * * figures 1,2 * * page 191, column 2, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/j.ab.2009.04.021
 [Y]  - LUNDKVIST M ET AL, "Characterization of anti-natalizumab antibodies in multiple sclerosis patients", MULTIPLE SCLEROSIS JOURNAL, (201305), vol. 19, no. 6, pages 757 - 764, XP008175740 [Y] 1-20 * the whole document * * page 758 *

DOI:   http://dx.doi.org/10.1177/1352458512462920
 [Y]  - L X TIEFENAUER ET AL, "Antibody coating loo. using various avidin-biotin complexes employed to an enzyme immunoassay for estradiol", FRESENIUS Z ANAL CHEM, (19880101), vol. 330, page 342, XP055180626 [Y] 1-20 * the whole document * * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.